<DOC>
	<DOCNO>NCT02712944</DOCNO>
	<brief_summary>The purpose trial evaluate effect testosterone replacement men renal failure ( dialysis ) also low testosterone . Specifically , investigator assess change requirement Erythropoietin Stimulating agent .</brief_summary>
	<brief_title>Testosterone Replacement Renal Failure</brief_title>
	<detailed_description>Testosterone replacement increase hemoglobin count . This therefore decrease requirement Erythropoietin Stimulating agent .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Men age 1880 year age . 2 . Renal failure hemodialysis 3 . Free testosterone &lt; 5 ng/dl . 4 . Willing randomized intramuscular ( IM ) testosterone placebo 5 . Currently get intravenous Epoetin alfa 1 . Use testosterone treatment currently past 6 month , include use counter androgen contain health supplement . 2 . Congestive heart Failure , class III IV . 3 . Baseline hemoglobin &gt; 12 g/dl . 4 . Allergic reaction testosterone Vehicle ( i.e . Peanut oil ) 5. prostate specific antigen &gt; 4 ng/ml . 6 . History Prostate Cancer . 7 . Liver enzymes &gt; twice upper limit normal . 8 . HIV hepatitis C. 9 . Severe untreated obstructive sleep apnea ( define apneahypopnea index &gt; 30 ) . 10 . Subjects warfarin blood thinner . 11 . Active infection ( foot ulcer ) 12 . History adverse event testosterone use past .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>